People Briefs: St. Jude Medical, JenaValve Technology, Staar Surgical, ElectroCore
This article was originally published in The Gray Sheet
St. Jude Medical names Zimmer Biomet CEO David Dvorak to board of directors, JenaValve appoints CFO, electroCore taps chief medical officer, and Staar Surgical names VP, research & development.
You may also be interested in...
Zimmer Biomet is now the second-largest orthopedic device maker behind Johnson & Johnson now that the merger between the two firms is complete. The companies divested some U.S. knee, elbow and bone cement assets in conjunction with finalized the deal after having sold of some European assets earlier in the year.
An expert panel foresees increased adoption of digital tools in the OR, not just robotics. These tools help surgeons make more informed decisions and improve outcomes, but barriers remain.
Advances in small activating RNAs, pioneered by MiNA Therapeutics, have caught the eye of Eli Lilly, and could be the next platform to exploit gene control mechanisms to produce a new therapeutic modality.